<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="specific inflammation in mice that had been infected by two" exact="influenza" post="virus strains, A/chicken/Kurgan/5/2005 (H5N1) and A/Hamburg/2009 MA (H1N1), was"/>
 <result pre="was shown to induce interferon-β synthesis, both in healthy and" exact="influenza" post="A virus-infected mice, and to promote production of antiviral"/>
 <result pre="of antiviral antibodies in the blood of the influenza-infected animals." exact="influenza" post="virus H5N1 H1N1 Rhodobacter capsulatus PG lipopolysaccharide mice antiviral"/>
 <result pre="stimulating the response of innate immune cells to pathogens, including" exact="influenza" post="viruses [4]. TLR4 can be activated by damage-associated molecular"/>
 <result pre="which are molecular structures released by virus-infected cells [5]. Different" exact="influenza" post="strains activate cells through various mechanisms, which lead to"/>
 <result pre="to protect mice from death caused by the mouse-adapted H1N1" exact="influenza" post="virus [8]. The nuclear non-histone high mobility group box"/>
 <result pre="is involved in the development of both gram-negative sepsis and" exact="influenza" post="complications, interacting with MD-2 and activating TLR4 [5, 9,"/>
 <result pre="of TLR4 by Eritoran can significantly reduce mouse mortality from" exact="avian influenza" post="[8]. A lipopolysaccharide (LPS) from a phototrophic bacterium R."/>
 <result pre="TLR4 by Eritoran can significantly reduce mouse mortality from avian" exact="influenza" post="[8]. A lipopolysaccharide (LPS) from a phototrophic bacterium R."/>
 <result pre="anti-inflammatory cytokines and survival rates of mice infected with various" exact="influenza" post="A strains. The study aim was to investigate the"/>
 <result pre="features of the inflammatory processes caused by H1N1 and H5N1" exact="influenza" post="viruses. EXPERIMENTAL The following ELISA kits were used: mouse"/>
 <result pre="the procedure described previously [16]. Viruses We used the following" exact="influenza" post="A virus strains: chicken/Kurgan/5/2005 (H5N1) and mouse-adapted Hamburg/2009 MA"/>
 <result pre="compliance with biological ethics in experiments on laboratory animals. Experimental" exact="influenza" post="infection in mice infected with the influenza virus strain"/>
 <result pre="laboratory animals. Experimental influenza infection in mice infected with the" exact="influenza" post="virus strain H5N1 Mice were divided into six groups"/>
 <result pre="ether anesthesia, intranasally (50 μL each) with the highly pathogenic" exact="avian influenza" post="virus H5N1 at doses of 10 to 105 TCID50"/>
 <result pre="anesthesia, intranasally (50 μL each) with the highly pathogenic avian" exact="influenza" post="virus H5N1 at doses of 10 to 105 TCID50"/>
 <result pre="the resulting serum was frozen at –20°C until the H5N1" exact="influenza" post="virus antibody titer in the serum was determined by"/>
 <result pre="experiment on the infection of mice with the A/chicken/Kurgan/5/2005 (H5N1)" exact="influenza" post="virus strain Experimental influenza infection in mice infected with"/>
 <result pre="of mice with the A/chicken/Kurgan/5/2005 (H5N1) influenza virus strain Experimental" exact="influenza" post="infection in mice infected with the mouse adapted influenza"/>
 <result pre="Experimental influenza infection in mice infected with the mouse adapted" exact="influenza" post="virus strain H1N1 The mice-adapted pandemic virus H1N1 used"/>
 <result pre="the HA, NP, PA, and PB1 proteins (Table). The H1N1" exact="influenza" post="virus is 105–fold more pathogenic for mice compared to"/>
 <result pre="ether anesthesia, intranasally (50 μL each) with the mouse-adapted H1N1" exact="influenza" post="virus at doses of 10 and 300 TCID50 per"/>
 <result pre="at –20 °C until the serum levels of the H1N1" exact="influenza" post="virus IgG1 and IgG2a antibodies were determined by ELISA."/>
 <result pre="on the infection of mice with the A/Hamburg/2009 MA (H1N1)" exact="influenza" post="virus strain Determining Cytokine Levels Levels of TNF-α, IL-6,"/>
 <result pre="in the blood serum of mice infected with the H1N1" exact="influenza" post="virus were determined using ELISA kits according to the"/>
 <result pre="analyzer (Awareness, USA) at a wavelength of 450 nm. Determining" exact="influenza" post="virus antibody levels EXPERIMENTAL PROCEDURES To determine the levels"/>
 <result pre="of antibodies to hemagglutinin (HA) of the H5N1 and H1N1" exact="influenza" post="viruses in the serum of the mice, allantoic fluid"/>
 <result pre="to the administration of the Rb. LPS, A/chicken/Kurgan/ 5/2005 (H5N1)" exact="influenza" post="virus, and both factors simultaneously The condition of the"/>
 <result pre="that had received 103, 104, and 105 TCID50 of the" exact="influenza" post="virus died by day 10 after the infection, regardless"/>
 <result pre="administration of the Rb. LPS to mice infected with the" exact="influenza" post="virus at a dose of 102 TCID50 increased their"/>
 <result pre="to the administration of the Rb. LPS, A/chicken/ Kurgan/5/2005 (H5N1)" exact="influenza" post="virus, and both factors simultaneously The administration of the"/>
 <result pre="infection with a dose of 10 TCID50 of the H1N1" exact="influenza" post="virus, followed by the administration of the Rb. LPS,"/>
 <result pre="(day 12). In the group of mice infected with the" exact="influenza" post="virus at a dose of 300 TCID50, 14% of"/>
 <result pre="the administration of the Rb. LPS, A/Hamburg/ 2009 MA (H1N1)" exact="influenza" post="virus, and both factors simultaneously Survival and weight changes"/>
 <result pre="changes in the animals infected with the H5N1 or H1N1" exact="influenza" post="virus revealed the absence of a protective effect on"/>
 <result pre="infection was shown to protect mice from the A/PR/8/34 (H1N1)" exact="influenza" post="virus. Protection from DAMPs released from influenza infected and"/>
 <result pre="the A/PR/8/34 (H1N1) influenza virus. Protection from DAMPs released from" exact="influenza" post="infected and destroyed cells that occurred through the TLR4-"/>
 <result pre="the administration of the Rb. LPS, A/ Hamburg/2009 MA (H1N1)" exact="influenza" post="virus, and both factors simultaneously Signs of viral infection"/>
 <result pre="to the administration of the Rb. LPS, A/Hamburg/2009 MA (H1N1)" exact="influenza" post="virus, and both factors simultaneously. A – TNF-α, B"/>
 <result pre="that exceeded the baseline level 3-fold by day 5. The" exact="influenza" post="virus, regardless of the dose, had no effect on"/>
 <result pre="to the administration of the Rb. LPS to mice. The" exact="influenza" post="virus increases the blood IFN-γ level in mice in"/>
 <result pre="of the Rb. LPS to mice infected with the H1N1" exact="influenza" post="virus reduced IFN-γ production in their blood (Fig. 7D)."/>
 <result pre="level increased 3-fold by day 5 of the experiment. The" exact="influenza" post="virus at a dose of 300 TCID50 significantly increased"/>
 <result pre="mice infected with 10 TCID50 and 300 TCID50 of the" exact="influenza" post="virus enhanced or decreased, respectively, the cytokine level, compared"/>
 <result pre="cytokine level, compared to that in mice infected with the" exact="influenza" post="virus alone (Fig. 7E). These results demonstrated that the"/>
 <result pre="the virus strains under study. IFN-β, a component of the" exact="influenza" post="vaccine, acts as a powerful adjuvant and helps induce"/>
 <result pre="a viral infection, has a protective and neutralizing effect against" exact="influenza" post="viruses. Expression of type I IFN and generation of"/>
 <result pre="LPS on the levels of antibodies to the A/chicken/Kurgan/5/2005 (H5N1)" exact="influenza" post="virus in the serum of mice survived by day"/>
 <result pre="***p &amp;lt; 0.001 The action of existing vaccines against an" exact="influenza" post="virus infection is based mainly on the induction of"/>
 <result pre="and B – IgG2a antibodies to the A/Hamburg/2009 MA (H1N1)" exact="influenza" post="virus (virus dose of 10 TCID50) in the serum"/>
 <result pre="IFN-β level in mice infected with various doses of the" exact="influenza" post="virus. IFN-β promotes antibody production by acquired immunity cells"/>
 <result pre="of antibodies in the blood of animals infected with the" exact="influenza" post="A virus (Fig. 8, Fig. 9). CONCLUSION Our study"/>
 <result pre="IFN-β both in healthy mice and in animals infected with" exact="influenza" post="A/chicken/Kurgan/ 5/2005 (H5N1) and A/Hamburg/2009 MA (H1N1) strains and"/>
</results>
